Artur Isaev

Employment

• Genetico CEO
  2012 - Present
• Human Stem Cells Institute PJSC (Russia)
  2003 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (68)

• Antigen Format Determines Immunogenicity of AAV-Based SARS-CoV-2 Vaccines: Full-Length Spike Versus Truncated Subunits
  Vaccines 2025 DOI: 10.3390/vaccines13121187
  +Save
• Genetic Landscape of Solid Malignant Tumors in a Russian Cohort of Patients
  Diagnostics 2025 DOI: 10.3390/diagnostics16010001
  +Save
• Current status of biomedical products for gene and cellular therapy of recessive dystrophic epidermolysis bullosa (part I)
  Russian Journal of Clinical Dermatology and Venereology 2025 DOI: 10.17116/klinderma202524021123
  +Save
• Assessment of physiological parameters in the application of a double adeno-associated virus 9 with a codon-optimized DYSF gene for limb girdle muscular dystrophy type R2
  Research Results in Pharmacology 2025 DOI: 10.18413/rrpharmacology.11.642
  +Save
• Current status of biomedical products for gene and cellular therapy of recessive dystrophic epidermolysis bullosa (review, part II)
  Russian Journal of Clinical Dermatology and Venereology 2025 DOI: 10.17116/klinderma202524031269
  +Save
• Calpainopathy (limb-girdle muscular dystrophy type R1): clinical features, diagnostic approaches, and biotechnological treatment methods
  Journal of Neuromuscular Diseases 2025 DOI: 10.1177/22143602251345967
  +Save
• Current status of biomedical products for gene and cellular therapy of recessive dystrophic epidermolysis bullosa (review, part III)
  Russian Journal of Clinical Dermatology and Venereology 2025 DOI: 10.17116/klinderma202524041395
  +Save
• Current status of biomedical products for gene and cell therapy of recessive dystrophic epidermolysis bullosa (review, part IV)
  Russian Journal of Clinical Dermatology and Venereology 2025 DOI: 10.17116/klinderma202524051551
  +Save
• Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine, Against Various Strains of SARS-CoV-2
  Vaccines 2024 DOI: 10.3390/vaccines12101200
  +Save
• The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma
  Head and neck tumors (HNT) 2023 DOI: 10.17650/2222-1468-2023-13-1-51-58
  +Save